1,3,5-triaza-7-phosphaadamantane has been researched along with Body Weight in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gandin, V; Giorgetti, M; Marzano, C; Porchia, M; Tisato, F; Trenti, A; Trevisi, L; Zanusso, I | 1 |
1 other study(ies) available for 1,3,5-triaza-7-phosphaadamantane and Body Weight
Article | Year |
---|---|
Homoleptic phosphino copper(I) complexes with in vitro and in vivo dual cytotoxic and anti-angiogenic activity.
Topics: Adamantane; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Copper; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Organophosphorus Compounds; Phosphines | 2015 |